Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial

Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial

ObjectivesThe aim of this study is to assess whether restaging transurethral resection (ReTUR) could be safely replaced with urine cytology (UC) and in-office fiexible cystoscopy in selected T1 non-muscle-invasive bladder cancer (NMIBC).Materials and MethodsThis is an ongoing prospective multicenter...

Full description

Bibliographic Details
Main Authors: Roberto Contieri, Giovanni Lughezzani, Nicolò Maria Buffi, Gianluigi Taverna, Alessandro Giacobbe, Emanuele Micheli, Sabato Barra, Piergiuseppe Colombo, Elena Vanni, Giorgio Guazzoni, Massimo Lazzeri, Rodolfo Hurle, HuNIRe Study Group, Paolo Casale, Alberto Saita, Andrea Gobbo, Edoardo Beatrici, Pier Paolo Avolio, Alessandro Uleri, Marco Paciotti, Vittorio Fasulo, Nicola Frego, Davide Maffei, Pietro Diana, Matteo Zanoni, Luigi Domanico, Devis Collura, Maria Grazia Elefante, Miriam Cieri
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
second resection
outcome
cystoscopy
urine cytology
non-muscle-invasive bladder cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.879399/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.879399/full

Similar Items